Keyword Search Results for "heart failure"

Zaret, Barry L., Wackers, Frans J., Terrin, Michael, Ross, Richard, Knatterud, Genell, Braunwald, Eugene Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trail Journal of the American College of Cardiology. 1991;17(2, Supplement 1):A214.

Wylie, J. V., Murphy, S. A., Morrow, D. A., de Lemos, J. A., Antman, E. M., Cannon, C. P. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 Am Heart J. 2004;148(1):173-80. Abstract

Kashani, A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(2):228-33. Abstract

O'Donoghue, M., Chen, A., Baggish, A. L., Anwaruddin, S., Krauser, D. G., Tung, R., Januzzi, J. L. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Card Fail. 2005;11(5 Suppl):S9-14. Abstract

Scirica, B. M., Morrow, D. A., Cannon, C. P., Ray, K. K., Sabatine, M. S., Jarolim, P., Shui, A., McCabe, C. H., Braunwald, E. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study J Am Coll Cardiol. 2006;47(11):2326-31.

Januzzi, J. L., Jr., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O'Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R., Lewandrowski, K. B., Lloyd-Jones, D. M., Wu, A. H. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol. 2007;50(7):607-13. Abstract

O'Donoghue, M., Kenney, P., Oestreicher, E., Anwaruddin, S., Baggish, A. L., Krauser, D. G., Chen, A., Tung, R., Cameron, R., Januzzi, J. L., Jr. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study) Am J Cardiol. 2007;100(9):1336-40. Abstract

Cannon, C. P., Greenberg, B. H. Risk stratification and prognostic factors in the post-myocardial infarction patient Am J Cardiol. 2008;102(5A):13G-20G. Abstract

Scirica, B. M., Cannon, C. P., Sabatine, M. S., Jarolim, P., Sloane, S., Rifai, N., Braunwald, E., Morrow, D. A. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem. 2009;55(2):265-73.

Bonaca, Marc P., Kudinova, Anastacia, Kakkar, Rahul, Scirica, Benjamin S., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A. ST2 and the Risk of CV Death or Heart Failure in Patients with Non-ST elevation Acute Coronary Syndromes (NSTE-ACS): Observations from MERLIN-TIMI 36 Circulation. 2010;122(21):NA.

O'Donoghue, M., Braunwald, E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7(1):13-20. Abstract

Scirica, B. M., Morrow, D. A., Bode, C., Ruzyllo, W., Ruda, M., Oude Ophuis, A. J., Lopez-Sendon, J., Swedberg, K., Ogorek, M., Rifai, N., Lukashevich, V., Maboudian, M., Cannon, C. P., McCabe, C. H., Braunwald, E. Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial European heart journal. 2010;31(16):1993-2005. Abstract

Nazer, B., Ray, K. K., Sloan, S., Scirica, B., Morrow, D. A., Cannon, C. P., Braunwald, E. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome European heart journal. 2011;32(11):1390-7. Abstract

Grandin, E. W., Jarolim, P., Murphy, S. A., Ritterova, L., Cannon, C. P., Braunwald, E., Morrow, D. A. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clinical chemistry. 2012;58(1):267-73. Abstract

Shah, R. V., Holmes, D., Anderson, M., Wang, T. Y., Kontos, M. C., Wiviott, S. D., Scirica, B. M. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry Circ Heart Fail. 2012;5(6):693-702. Abstract

Anderson, M. L., Peterson, E. D., Peng, S. A., Wang, T. Y., Ohman, E. M., Bhatt, D. L., Saucedo, J. F., Roe, M. T. Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification: A Report From NCDR Circ Cardiovasc Qual Outcomes. 2013;6(6):708-15. Abstract

Braunwald, E. Research Advances in Heart Failure: A Compendium Circ Res. 2013;NA(NA):NA. Abstract

Bui, A. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., Fonarow, G. C. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Am Heart J. 2013;165(4):567-574 e6. Abstract

Chen, H. H., Abouezzeddine, O. F., Anstrom, K. J., Givertz, M. M., Bart, B. A., Felker, G. M., Hernandez, A. F., Lee, K. L., Braunwald, E., Redfield, M. M. Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit?: Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial Circ Heart Fail. 2013;6(5):1087-94.

Givertz, M. M., Mann, D. L., Lee, K. L., Ibarra, J. C., Velazquez, E. J., Hernandez, A. F., Mascette, A. M., Braunwald, E. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study Circ Heart Fail. 2013;6(4):862-8.

Goel, K., Pinto, D. S., Gibson, C. M. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review Am Heart J. 2013;165(4):451-67. Abstract

Hess, P. L., Grau-Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Bhatt, D. L., Schwamm, L. H., Yancy, C. W., Fonarow, G. C., Al-Khatib, S. M., for the Get with The Guidelines Steering, Committee, Hospitals, Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure J Cardiovasc Electrophysiol. 2013;NA(NA):NA. Abstract

Hsich, E. M., Grau-Sepulveda, M. V., Hernandez, A. F., Eapen, Z. J., Xian, Y., Schwamm, L. H., Bhatt, D. L., Fonarow, G. C. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline-Heart Failure Registry Am Heart J. 2013;166(6):1063-1071 e3. Abstract

Kohli, P., Steg, P. G., Cannon, C. P., Smith, S. C., Jr., Eagle, K. A., Ohman, E. M., Alberts, M. J., Hoffman, E., Guo, J., Simon, T., Sorbets, E., Goto, S., Bhatt, D. L., Reach Registry Investigators NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Am J Med. 2013;NA(NA):NA. Abstract

Motiwala, S. R., Sarma, A., Januzzi, J. L., O'Donoghue, M. L. Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently? Clin Chem. 2013;NA(NA):NA. Abstract

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., Deswal, A., Stevenson, L. W., Givertz, M. M., Ofili, E. O., O'Connor, C. M., Felker, G. M., Goldsmith, S. R., Bart, B. A., McNulty, S. E., Ibarra, J. C., Lin, G., Oh, J. K., Patel, M. R., Kim, R. J., Tracy, R. P., Velazquez, E. J., Anstrom, K. J., Hernandez, A. F., Mascette, A. M., Braunwald, E., Relax Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA. 2013;309(12):1268-77. Abstract

Scirica, Benjamin M, Raz, Itamar, Cavender, Matthew A, Steg, P. G, Hirshberg, Boaz, Davidson, Jaime, Im, KyungAh, Hoffman, Elaine, Braunwald, Eugene, Bhatt, Deepak L Abstract 17503: Outcomes of Patients With Type 2 Diabetes and Known Congestive Heart Failure Treated With Saxagliptin: Analyses of the SAVOR-TIMI 53 Study Circulation. 2013;128(22 Supplement):A17503.

Zakeri, R., Borlaug, B. A., McNulty, S., Mohammed, S. F., Lewis, G. D., Semigran, M. J., Deswal, A., Lewinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2013;NA(NA):NA. Abstract

Braunwald, E. Responsiveness to loop diuretics in heart failure Eur Heart J. 2014;NA(NA):NA.

Mohammed, S. F., Borlaug, B. A., McNulty, S., Lewis, G. D., Lin, G., Zakeri, R., Semigran, M. J., LeWinter, M., Hernandez, A. F., Braunwald, E., Redfield, M. M. Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study Circ Heart Fail. 2014;NA(NA):NA. Abstract

Setoguchi, S., Warner Stevenson, L., Stewart, G. C., Bhatt, D. L., Epstein, A. E., Desai, M., Williams, L. A., Chen, C. Y. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure BMJ. 2014;348(NA):g2866. Abstract